NT$
28.10
May 9
Business Description
Mytrex Health Technologies Inc
NAICS : 332911
SIC : 3491
ISIN : TW0004431002
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.74 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.48 | |||||
Debt-to-EBITDA | 7.09 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.13 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.4 | |||||
3-Year EBITDA Growth Rate | -55.5 | |||||
3-Year Book Growth Rate | -11.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.75 | |||||
9-Day RSI | 52.32 | |||||
14-Day RSI | 50.8 | |||||
6-1 Month Momentum % | 5.85 | |||||
12-1 Month Momentum % | -34.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.52 | |||||
Quick Ratio | 1.06 | |||||
Cash Ratio | 0.54 | |||||
Days Inventory | 65.18 | |||||
Days Sales Outstanding | 33.91 | |||||
Days Payable | 38.17 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -12.01 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 14.88 | |||||
Operating Margin % | -5.46 | |||||
Net Margin % | -4.35 | |||||
FCF Margin % | -2.26 | |||||
ROE % | -7.16 | |||||
ROA % | -4.23 | |||||
ROIC % | -8.74 | |||||
ROC (Joel Greenblatt) % | -12.36 | |||||
ROCE % | -5.41 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 21.54 | |||||
PS Ratio | 0.79 | |||||
PB Ratio | 1.52 | |||||
Price-to-Tangible-Book | 1.74 | |||||
EV-to-EBIT | -21.83 | |||||
EV-to-EBITDA | 24.16 | |||||
EV-to-Revenue | 0.86 | |||||
EV-to-FCF | -38 | |||||
Price-to-Projected-FCF | 0.9 | |||||
Price-to-Median-PS-Value | 0.65 | |||||
Price-to-Net-Current-Asset-Value | 11.61 | |||||
Earnings Yield (Greenblatt) % | -4.58 | |||||
FCF Yield % | -2.85 | |||||
Forward Rate of Return (Yacktman) % | 4.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mytrex Health Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 1,292.969 | ||
EPS (TTM) (NT$) | -1.542 | ||
Beta | 0.16 | ||
Volatility % | 44.68 | ||
14-Day RSI | 50.8 | ||
14-Day ATR (NT$) | 0.561173 | ||
20-Day SMA (NT$) | 27.9825 | ||
12-1 Month Momentum % | -34.84 | ||
52-Week Range (NT$) | 24.7 - 42 | ||
Shares Outstanding (Mil) | 36.54 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mytrex Health Technologies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mytrex Health Technologies Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Mytrex Health Technologies Inc Frequently Asked Questions
What is Mytrex Health Technologies Inc(ROCO:4431)'s stock price today?
When is next earnings date of Mytrex Health Technologies Inc(ROCO:4431)?
Does Mytrex Health Technologies Inc(ROCO:4431) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |